Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 15:26:02 GMT 2023
by
admin
on
Sat Dec 16 15:26:02 GMT 2023
|
| Protein Type | REGULATOR PROTEIN |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
AYN2H2T5GU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
260308
Created by
admin on Sat Dec 16 15:26:02 GMT 2023 , Edited by admin on Sat Dec 16 15:26:02 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C190421
Created by
admin on Sat Dec 16 15:26:02 GMT 2023 , Edited by admin on Sat Dec 16 15:26:02 GMT 2023
|
PRIMARY | |||
|
80295-65-4
Created by
admin on Sat Dec 16 15:26:02 GMT 2023 , Edited by admin on Sat Dec 16 15:26:02 GMT 2023
|
NO STRUCTURE GIVEN | |||
|
2640087-71-2
Created by
admin on Sat Dec 16 15:26:02 GMT 2023 , Edited by admin on Sat Dec 16 15:26:02 GMT 2023
|
PRIMARY | |||
|
P08603
Created by
admin on Sat Dec 16 15:26:02 GMT 2023 , Edited by admin on Sat Dec 16 15:26:02 GMT 2023
|
PRIMARY | |||
|
AYN2H2T5GU
Created by
admin on Sat Dec 16 15:26:02 GMT 2023 , Edited by admin on Sat Dec 16 15:26:02 GMT 2023
|
PRIMARY | |||
|
12202
Created by
admin on Sat Dec 16 15:26:02 GMT 2023 , Edited by admin on Sat Dec 16 15:26:02 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_3 | 1_48 |
| 1_34 | 1_62 |
| 1_67 | 1_111 |
| 1_96 | 1_123 |
| 1_128 | 1_174 |
| 1_160 | 1_187 |
| 1_192 | 1_233 |
| 1_219 | 1_244 |
| 1_249 | 1_291 |
| 1_276 | 1_302 |
| 1_307 | 1_356 |
| 1_339 | 1_367 |
| 1_371 | 1_413 |
| 1_398 | 1_424 |
| 1_430 | 1_476 |
| 1_459 | 1_487 |
| 1_491 | 1_535 |
| 1_518 | 1_546 |
| 1_551 | 1_593 |
| 1_579 | 1_605 |
| 1_612 | 1_655 |
| 1_641 | 1_666 |
| 1_673 | 1_715 |
| 1_701 | 1_726 |
| 1_735 | 1_774 |
| 1_763 | 1_785 |
| 1_821 | 1_846 |
| 1_852 | 1_897 |
| 1_883 | 1_908 |
| 1_913 | 1_955 |
| 1_941 | 1_966 |
| 1_971 | 1_1014 |
| 1_1000 | 1_1025 |
| 1_1030 | 1_1073 |
| 1_1059 | 1_1084 |
| 1_1091 | 1_1134 |
| 1_1120 | 1_1145 |
| 1_1149 | 1_1200 |
| 1_1183 | 1_1210 |
| 1_793 | 1_835 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_511 |
| N | 1_700 |
| N | 1_784 |
| N | 1_804 |
| N | 1_864 |
| N | 1_893 |
| N | 1_1011 |
| N | 1_1077 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
LIGAND->TARGET |
PRECLINICAL
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
For the treatment of dry age-related macular degeneration (AMD).
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT | CHEMICAL |
|